共 18 条
[1]
Zhang X.H., Lu Z.L., Liu L., Coronary heart disease in China, Heart, 94, pp. 1126-1131, (2008)
[2]
Jiang G., Wang D., Li W., Et al., Coronary heart disease mortality in China: age, gender, and urban-rural gaps during epidemiological transition, Rev Panam Salud Publica, 31, pp. 317-324, (2012)
[3]
Gaziano T.A., Opie L.H., Weinstein M.C., Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis, Lancet, 368, pp. 679-686, (2006)
[4]
Perk J., De Backer G., Gohlke H., Et al., European guidelines on cardiovascular disease prevention in clinical practice (version 2012), Eur Heart J, 33, pp. 1635-1701, (2012)
[5]
Guidelines for cardiac rehabilitation and secondary prevention programs, (2013)
[6]
Jones K., Saxon L., Cunningham W., Et al., Secondary prevention for patients after a myocardial infarction: summary of updated NICE guidance, BMJ, 347, (2013)
[7]
Liu H., Yu J., Pan C., Et al., Cross-sectional study on the prevalence of metabolic syndrome in patients with coronary heart disease in China, Natl Med J China, 86, pp. 2095-2098, (2006)
[8]
Teo K., Lear S., Islam S., Et al., Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle-and low-income countries: the Prospective Urban Rural Epidemiology (PURE) study, JAMA, 309, pp. 1613-1621, (2013)
[9]
Yusuf S., Islam S., Chow C.K., Et al., Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey, Lancet, 378, pp. 1231-1243, (2011)
[10]
Bi Y., Gao R., Patel A., Et al., Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study, Am Heart J, 157, pp. 509-516, (2009)